Navigation Links
Hologic Announces Fourth Quarter Fiscal 2013 Operating Results
Date:11/11/2013

ssociated with acquisitions, including without limitation, the Company's ability to successfully integrate acquired businesses, the risks that the acquired businesses may not operate as effectively and efficiently as expected even if otherwise successfully integrated, the risks that acquisitions may involve unexpected costs or unexpected liabilities, including the risks and challenges associated with the Company's recent acquisition of Gen‐Probe and operations in China; the risks of conducting business internationally; the risk of adverse exchange rate fluctuations on the Company's international activities and businesses; manufacturing risks, including the Company's reliance on a single or limited source of supply for key components, and the need to comply with especially high standards for the manufacture of many of its products; the Company's ability to predict accurately the demand for its products, and products under development, and to develop strategies to address its markets successfully; the early stage of market development for certain of the Company's products; the Company's leverage risks, including the Company's obligation to meet payment obligations and financial covenants associated with its debt; risks related to the use and protection of intellectual property; expenses, uncertainties and potential liabilities relating to litigation, including, without limitation, commercial, intellectual property, employment and product liability litigation; technical innovations that could render products marketed or under development by the Company obsolete; and competition.

The risks included above are not exhaustive. Other factors that could adversely affect the company's business and prospects are described in the filings made by the Company with the SEC. The Company expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any such statements presented herein to reflect any change in expectations or any chan
'/>"/>

SOURCE Hologic, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

Related medicine technology :

1. Hologic, Inc. Enhances Physician Training With Virtual Reality Simulation
2. FDA Approves Aptima HPV 16 18/45 Genotype Assay for Use on Hologics Panther System
3. Hologic to Host Investor Presentation at RSNA 2013
4. Hologic to Mark Start of Breast Cancer Awareness Month with NASDAQ Opening Bell Ceremony
5. Hologic to Present at Two Upcoming Investor Conferences
6. Hologic Announces Third Quarter Fiscal 2013 Operating Results
7. Hologic Announces Completion of Term Loan B Repricing
8. FDA Clears Hologics Single Energy Femur Exam to Visualize Features Associated with Developing Atypical Femur Fractures on a DXA Platform
9. FDA APPROVES APTIMA HPV ASSAY FOR USE ON HOLOGICS PANTHER SYSTEM
10. Hologic Appoints Jack W. Cumming President and Chief Executive Officer
11. Commercial Release of 3D (Breast Tomosynthesis) Biopsy Option Strengthens Hologics Position as Provider of the Nations Most Comprehensive Portfolio of Interventional Breast Health Solutions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2014)...  EHE International, the recognized leader in preventive medicine ... today announced that Dignity Health Medical Group Nevada, LLC  ... been named an EHE-certified preventive care center. Through Dignity, ... region now have greater access to EHE,s preventive ... "EHE is proud to add Dignity Health ...
(Date:7/21/2014)... 21, 2014 According ... Research "E-Clinical Solution Software Market- Global Industry Analysis, Size, ... global microfluidic device market was valued at USD 3,005 ... a CAGR of 13.8% from 2014 to 2020, to ... 2020. Browse the full E-Clinical Solution Software Market ...
(Date:7/21/2014)... -- By order of the U.S. Bankruptcy Court, Tiger Group,s ... and optical equipment, designer eyeglass frames, and other assets of ... Services LLC. Online bidding opens July 21 at ... auction style, on July 28 beginning at 10:30 a.m. (ET). ... July 25 th and 26 th at 12 ...
Breaking Medicine Technology:EHE International Certifies Dignity Health Medical Group Nevada, LLC as Its Newest Partner 2E-Clinical Solution Software Market is expected to reach USD 6,515.3 million in 2020: Transparency Market Research 2E-Clinical Solution Software Market is expected to reach USD 6,515.3 million in 2020: Transparency Market Research 3E-Clinical Solution Software Market is expected to reach USD 6,515.3 million in 2020: Transparency Market Research 4E-Clinical Solution Software Market is expected to reach USD 6,515.3 million in 2020: Transparency Market Research 5Auction Set For Assets Of National Optical Services Company 2
... CAESAREA, Israel, May 2, 2012 Angioslide ... announced that it has received FDA 510(K) clearance for ... Disease in below the knee (BTK) vasculature.  The new ... potential use of PROTEUS technology.   Angioslide,s ...
... NBIX ) today announced its financial results for ... of 2012, the Company reported net loss of $0.9 million, ... of $2.9 million, or $0.05 income per share, for the ... results is primarily due to the Company,s VMAT2 program moving ...
Cached Medicine Technology:Angioslide Announces FDA 510(K) Clearance of PROTEUS(TM) Below The Knee Device 2Neurocrine Biosciences Reports First Quarter 2012 Results 2Neurocrine Biosciences Reports First Quarter 2012 Results 3Neurocrine Biosciences Reports First Quarter 2012 Results 4Neurocrine Biosciences Reports First Quarter 2012 Results 5Neurocrine Biosciences Reports First Quarter 2012 Results 6
(Date:7/21/2014)... that HIV and its monkey equivalent, SIV, gain a ... making it difficult to completely eliminate the virus even ... report that SIV can become entrenched in tissues fewer ... detectable in blood plasma (the liquid part) or blood ... Ph.D., of Beth Israel Deaconess Medical Center and the ...
(Date:7/21/2014)... CA (PRWEB) July 21, 2014 Ticket Down ... Manchester United tickets at the Rose Bowl . One of ... will be taking part in the 2014 Guinness International Champions Cup, ... The popular member of the English Premier League will get a ... travel to the Rose Bowl in Pasadena, Calif. for the Chevrolet ...
(Date:7/21/2014)... July 21, 2014 The New ... mesh lawsuits ( http://www.transvaginalmeshlawsuithelp.com/ ) filed against ... awarded last year to the Plaintiff in the ... Judge Carol Higbee of Atlantic County Superior Court ... judgment notwithstanding the verdict on July 15th, noting ...
(Date:7/21/2014)... July 21, 2014 (HealthDay News) -- A recently developed molecular ... in the lab. The team of scientists at Temple ... one day lead to a permanent treatment for HIV. They ... a vaccine to offer protection against the disease in the ... system, removal of the virus is required in order to ...
(Date:7/21/2014)... By Dennis Thompson ... (HealthDay News) -- Despite recent advances in preventing heart ... have occurred among middle-aged adults -- especially women, a ... young and middle-aged adults have remained stable during the ... a better than 20 percent decline in heart attacks, ...
Breaking Medicine News(10 mins):Health News:NIH-supported scientists demonstrate very early formation of SIV reservoir 2Health News:LA Galaxy vs. Manchester United Tickets Rose Bowl: Ticket Down Cuts Chevrolet FC Cup Ticket Prices For ManU vs. LA Galaxy in Pasadena on July 23rd 2Health News:LA Galaxy vs. Manchester United Tickets Rose Bowl: Ticket Down Cuts Chevrolet FC Cup Ticket Prices For ManU vs. LA Galaxy in Pasadena on July 23rd 3Health News:Court Overseeing First Ethicon Transvaginal Mesh Lawsuit Trial in New Jersey Upholds $11 Million+ Jury Award, Bernstein Liebhard LLP Reports 2Health News:Court Overseeing First Ethicon Transvaginal Mesh Lawsuit Trial in New Jersey Upholds $11 Million+ Jury Award, Bernstein Liebhard LLP Reports 3Health News:Court Overseeing First Ethicon Transvaginal Mesh Lawsuit Trial in New Jersey Upholds $11 Million+ Jury Award, Bernstein Liebhard LLP Reports 4Health News:Scientists Snipped HIV Out of Human DNA 2Health News:No Change in Heart Attack Rates for Younger U.S. Adults 2Health News:No Change in Heart Attack Rates for Younger U.S. Adults 3
... of Medicine apparently have solved the riddle of why cancer ... mechanism that could lead to better cancer treatments. , ... laboratory in the Duke Department of Pharmacology and Cancer Biology, ... a way to avoid programmed cell death. They make use ...
... Alcon, Inc.,(NYSE: ACL ) announced today that ... PATANASE(R) (olopatadine hydrochloride) nasal spray for,the relief of ... 12,years of age and older. PATANASE(R) nasal spray, ... will be available in May of,this year., ...
... As the State of Nebraska,s Chief,Medical Officer, Joann ... health issues. The same goes for Gary Gorby, ... Medical Center. Right now, both,physicians are focusing on ... (Photo: http://www.newscom.com/cgi-bin/prnh/20080415/LATU118LOGO ), Dr. Schaefer, 40, ...
... Gift of Mobility Helps Teenager Attend Classes and Take ... Like many,15-year-olds, Rachel Wilhite enjoys hanging out with ... However, she is also struggling with a condition that ... relatively rare dwarfism that,has serious consequences. When the body ...
... Advertising and Medical Education ... Network, ... more than 15 years strategic and business-building,experience, has joined GHG Grey Healthcare ... Grey,Healthcare Group (GHG) is a WPP company and one of the world,s ...
... NEW YORK, April 15 GHG Grey Healthcare ... world,s leading healthcare communications firms,announced that Jennifer Samuels ... Services. Ms. Samuels has a wide range of ... industry, and an in-depth,knowledge of the oncology and ...
Cached Medicine News:Health News:A potential sugar fix for tumors 2Health News:Alcon's PATANASE(R) Nasal Spray Approved by FDA for Treatment of Nasal Allergy Symptoms 2Health News:Alcon's PATANASE(R) Nasal Spray Approved by FDA for Treatment of Nasal Allergy Symptoms 3Health News:Alcon's PATANASE(R) Nasal Spray Approved by FDA for Treatment of Nasal Allergy Symptoms 4Health News:Two Prominent Nebraska Doctors Become Patients in Living Donor Liver Transplant 2Health News:Two Prominent Nebraska Doctors Become Patients in Living Donor Liver Transplant 3Health News:Two Prominent Nebraska Doctors Become Patients in Living Donor Liver Transplant 4Health News:The SCOOTER Store Donates Power Chair to Teenager Struggling With Rare Dwarfism 2Health News:The SCOOTER Store Donates Power Chair to Teenager Struggling With Rare Dwarfism 3Health News:Susan Byrne joins GHG Grey Healthcare Group as EVP, Strategy and Business Development, Europe, a Newly-Created Position 2Health News:Jennifer Samuels Joins GHG Grey Healthcare Group as Executive Vice President, Account Services 2
Bioceramic orbital implants insert easily into orbital socket and will not cling to surrounding tissue. Improved interconnectivity between pores enhances vascularization. Implants may be easily drill...
Designed for the clockwise one-hand implantation of the Morcher Capsular Tension Ring....
... the Diagnosys electrophysiology system is the Espion. This ... support a wide variety of stimulators for different ... Function Testing ,The Espion system was designed ... the current standard clinical visual function tests, ERG, ...
... the heart of the Espion2 Electrophysiology system. ... aluminum chassis, real-time DSP, USB control, an ... differential amplifiers. The E2 connects to any ... over standard wi-fi Ethernet. The E2 includes ...
Medicine Products: